Catalyst Biosciences

SOUTH SAN FRANCISCO, Calif., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO) today announced that Nassim Usman, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference being held in New York City. The Catalyst Biosciences presentation will be held on Tuesday, September 26, 2017 at 3:30 p.m. Eastern Time.

About Catalyst 
Catalyst is a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia. For more information, please visit www.catalystbiosciences.com.

Contacts:

Investors:                                                                                
Fletcher Payne, CFO, Catalyst Biosciences                             
650.871.0761                                                                          
investors@catbio.com

Media:
Denise Powell
510.703.9491
denise@redhousecomms.com